Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
07 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/07/3110957/0/en/Allarity-Therapeutics-Announces-Appointment-of-Jeff-Ervin-as-Chief-Financial-Officer.html
30 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/30/3107402/0/en/Allarity-Therapeutics-Receives-Australian-Patent-Acceptance-Notice-for-Stenoparib-DRP-Companion-Diagnostic.html
27 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/27/3106506/0/en/Allarity-Therapeutics-Announces-Dosing-of-Second-Patient-in-New-Phase-2-Trial-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
11 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/11/3097932/0/en/Allarity-Therapeutics-Announces-Changes-to-Board-of-Directors.html
05 Jun 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/diagnostic-center/allarity-announces-enrolment-of-first-patient-in-phase-2-clinical-trial-protocol-of-stenoparib-in-advanced-ovarian-cancer-17245
04 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/04/3093497/0/en/Allarity-Therapeutics-Announces-Research-Collaboration-with-Indiana-Biosciences-Research-Institute-to-Further-Advance-Understanding-of-Stenoparib-s-Unique-Dual-Therapeutic-Mechanis.html
ABOUT THIS PAGE